Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections: The Impact of Baseline A1c
2004
We agree with Blumer’s (1) contention that patients with type 1 diabetes using continuous subcutaneous insulin infusion (CSII) therapy represent a well-motivated patient population. In this context, he asks whether differences in patient motivation (as reflected in adherence to frequent self-monitoring of blood glucose and regular contact with diabetes educators) may underlie the finding of improved glycemic control with CSII as compared with multiple daily insulin injection (MDII) therapy in our recent pooled analysis …
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
19
References
193
Citations
NaN
KQI